Pete De Spain
Senior Vice President of Investor Relations & Corporate CommunicationsMr. Pete De Spain is Senior Vice President of Investor Relations & Corporate Communications of MBX Biosciences, Inc. from November 2025. He served as Executive Vice President of Investor Relations & Corporate Communications at Kura Oncology, Inc since August 2023 and served as Senior Vice President of Investor Relations and Corporate Communications since February 2022 until August 2023 and served as its Vice President of Investor Relations and Corporate Communications since October 2017 until February 2022 and joined Kura in October 2017. He served as an Associate Director of Investor Relations & Corporate Communications of Favrille Inc. He served as the Vice President of Investor Relations and Corporate Communications at MEI Pharma, Inc., until October 27, 2017. Mr. De Spain served as Senior Director of Investor Relations and Corporate Communications at MEI Pharma, Inc. (alternate name: Marshall Edwards Inc.). Mr. De Spain served as Director of Investor Relations and Corporate Communications of Prometheus Laboratories Inc. He served as a Manager of Corporate Communications of Anadys Pharmaceuticals Inc. Previously, Mr. De Spain served in similar roles of increasing responsibility at Anadys Pharmaceuticals (acquired by Roche), Sequenom and Sunrise Medical. He serves on the board of the San Diego chapter of the National Investor Relations Institute (NIRI). Mr. De Spain received his bachelor's degree in communication with a public relations emphasis from San Diego State University.
Positions
- Company NameMBX Biosciences, Inc.Stock CodeMBXPositionSenior Vice President of Investor Relations & Corporate CommunicationsColleagues
- SLSteven L. HoerterExecutive Chairperson, CEO & President
- SASalomon AzoulayChief Medical Officer
- JWJohn W. SmitherChief Financial Officer
- JHJeffrey HeldChief Legal Officer
- PJPatrick James HeronIndependent Director
- OHOra Hirsch PescovitzIndependent Director
- LDLaurie D. StelzerIndependent Director
- ETEdward T. MathersIndependent Director
